A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample

Proceedings of the National Academy of Sciences of the United States of America
Camila GuindaliniGerome Breen

Abstract

The dopamine (DA) transporter DAT1 is a major target bound by cocaine in brain. We examined the influence of functional genetic variants in DAT1 on cocaine addiction. Repeat polymorphisms, including a 30-bp variable-number tandem repeat (VNTR) in intron 8 (Int8 VNTR) with two common alleles, were genotyped in cocaine-dependent abusers (n = 699) and in controls with no past history of drug abuse (n = 866) from São Paulo, Brazil. Positive association was observed with allele 3 of the Int8 VNTR and cocaine abuse (allele odds ratio = 1.2, 95% confidence interval = 1.01-1.37, P = 0.036; 3/3 homozygote odds ratio = 1.45, 95% confidence interval = 1.18-1.78, P = 0.0008). Population stratification was assessed and did not affect the results. Haplotypic analyses using additional polymorphisms indicated that the Int8 VNTR is responsible for the observed association. Functional analyses in reporter-gene constructs, demonstrated that allele 3 mediates significant (P < 0.05) but small reduced expression compared with the "protective" allele 2. This difference increased when 1 and 10 muM cocaine was added to the cell culture ( approximately 40% reduction of the 3 allele expression versus the 2 allele). The 3 allele also demonstrated approxim...Continue Reading

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·B HopeE J Nestler
Sep 1, 1985·Molecular and Cellular Biology·D Levens, P M Howley
Aug 1, 1987·Molecular and Cellular Biology·J P QuinnD Levens
Nov 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J GelernterP A Rao
Jan 1, 1994·Journal of Neural Transmission. General Section·K P LeschP Riederer
Apr 1, 1994·Molecular and Cellular Neurosciences·C F MorrisonJ P Quinn
Feb 1, 1993·Trends in Pharmacological Sciences·B Giros, M G Caron
Sep 26, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·D G Le CouteurS m Pond
Nov 18, 1998·Archives of General Psychiatry·K R MerikangasB J Rounsaville
Feb 2, 1999·The British Journal of Psychiatry : the Journal of Mental Science·K S Kendler, C A Prescott
Oct 19, 1999·Molecular Psychiatry·D E ComingsJ P MacMurray
Jul 19, 2000·Journal of Neurochemistry·P D WalkerM J Bannon
Apr 3, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D MartinezM Laruelle
Feb 13, 2002·Molecular Psychiatry·T A GreenwoodJ R Kelsoe
Mar 29, 2002·Nature Genetics·Ana ContenteMatthias Dobbelstein
Jun 5, 2002·Genome Research·W James KentDavid Haussler
Jun 18, 2002·Journal of Neurochemistry·Deborah C MashSari Izenwasser
Aug 3, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Marília Dalva TurchiAdauto Castelo
Jul 19, 2003·RNA·Jingyi HuiAlbrecht Bindereif
Aug 5, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Aiveen KirleyMichael Gill
Mar 9, 2004·Neuropeptides·Alasdair MacKenzie, John P Quinn
Aug 12, 2005·Psychiatric Genetics·Guilherme MessasHomero Vallada
Jan 24, 2006·BMC Public Health·Camila GuindaliniRonaldo Laranjeira

❮ Previous
Next ❯

Citations

Mar 4, 2009·Archives of General Psychiatry·Lindsay A FarrerJoel Gelernter
Jun 17, 2008·Der Nervenarzt·T J RennerK-P Lesch
Jun 10, 2009·Human Genetics·Ian R GizerIrwin D Waldman
Nov 12, 2013·Neuropeptides·John P QuinnVivien J Bubb
Nov 6, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Barbara FrankeAndreas Reif
Apr 29, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Julia K PinsonneaultWolfgang Sadee
Nov 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ainhoa BilbaoRainer Spanagel
Dec 19, 2006·Nucleic Acids Research·Yevgeniy GelfandGary Benson
Jun 2, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L K McCallumL R Griffiths
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Jibran Y KhokharRachel F Tyndale
Oct 28, 2006·Annual Review of Pharmacology and Toxicology·Maureen K Hahn, Randy D Blakely
Jan 5, 2008·Behavioral and Brain Functions : BBF·Camila GuindaliniGerome Breen
Aug 10, 2011·PloS One·Elena ShumayNora D Volkow
Apr 11, 2014·PloS One·Owen G O'DalySukhwinder S Shergill
Sep 13, 2013·Pharmacogenomics·Ying ZhaoZhicheng Lin
Apr 30, 2011·Neuroscience and Biobehavioral Reviews·Zsofia NemodaMaria Sasvari-Szekely
May 22, 2010·Psychiatry Research·Mostafa Saadat, Roghayyeh Vakili-Ghartavol
May 25, 2010·Sleep Medicine·Rogerio Santos-SilvaSergio Tufik
Apr 7, 2010·Sleep Medicine·Sergio TufikLia Rita Azeredo Bittencourt
Sep 1, 2009·Journal of Substance Abuse Treatment·Bradley T ConnerErnest P Noble
Jun 9, 2009·Appetite·Wendy Foulds MathesCynthia M Bulik
Sep 16, 2008·Neuroscience and Biobehavioral Reviews·Stephanie M GromanJ David Jentsch
May 12, 2007·Trends in Biochemical Sciences·Robert D Wells
Dec 17, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Florence F RoussotteUNKNOWN Alzheimer's Disease Neuroimaging Initiative (ADNI)
Jan 1, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Isabelle Ouellet-MorinCathy L Barr
Dec 3, 2008·The European Journal of Neuroscience·Shalini PadmanabhanBalakrishna M Prasad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.